Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
Disease Category: Endometriosis
Location: United States, OR
Clinical Trial Details
Research Study Summary
If you have endometriosis, you may qualify for a medical research study.
"A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe endometriosis-associated pain."
The purpose of this research study is to test the safety and effectiveness of the study drug at different doses compared to placebo in managing moderate to severe pain associated with endometriosis.
Participation in this study will last up to about 20 months and include 14 study visits to the study site and 7 study telephone contacts.
Patient Inclusion Criteria:
- Age 18-49
- Diagnosis of endometriosis
Patient Exclusion Criteria:
- Currently pregnant, or breast feeding
- Planning a pregnancy within the next 24 months.
To Learn more
Date Last Changed:
July 18, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these